T. Kawamori et al., EVALUATION OF BENZYL SELENOCYANATE GLUTATHIONE CONJUGATE FOR POTENTIAL CHEMOPREVENTIVE PROPERTIES IN COLON CARCINOGENESIS, International journal of oncology, 13(1), 1998, pp. 29-34
Observational, clinical and experimental studies have suggested that d
ietary supplementation with selenium can inhibit the development of co
lon cancer. Since toxicity and chemopreventive efficacy of selenium co
mpounds depend to a large extent, on the form of selenium the developm
ent of efficacious organoselenium compounds with low toxicity is being
pursued ih our laboratory. We have assessed the chemopreventive prope
rties of a newly synthesized organoselenium compound, benzyl selenocya
nate glutathione conjugate (BSeSG), and of benzyl selenocyanate (BSC),
as a positive control, using azoxymethane (AOM)-induced colonic aberr
ant crypt foci (ACF) as a measure of efficacy. Five-week-old male F344
rats were fed the control diet (modified AIN-76A) or experimental die
ts containing 10 or 20 ppm BSeSG (1.7 and 3.4 ppm as Se, respectively)
, or 10 ppm BSC (4.1 ppm as Se). One week later, all animals except th
ose in vehicle (normal saline)-treated groups were s.c. injected with
AOM (15 mg/kg of body weight, once weekly for 2 weeks). All animals we
re sacrificed 7 weeks after the last AOM injection, and the ACF, level
s of prostaglandin E-2 (PGE(2)), cyclooxygenase protein expression (CO
X-1 and -2), and glutathione S-transferase type mu (GST-mu) were deter
mined in the colon. As expected, dietary administration of BSC suppres
sed ACF development by about 37%. In rats administered 10 or 20 ppm BS
eSG, the frequencies of AOM-induced colonic ACF were significantly dec
reased compared to those of rats given AOM and control diet by about 4
1% (P<0.01) and 61% (P<0.001), respectively. Administration of BSeSG i
nhibited PGE(2) production (81-88% inhibition) via COX-2 synthesis in
the colonic mucosa (18-60% inhibition). Also, BSeSG increased GST-mu p
rotein activity in colonic mucosa (30-32% increase). These data sugges
t that a newly synthesized organoselenium compound, BSeSG might be a p
romising chemopreventive agent against colon carcinogenesis.